ALBEMARLE CORP (ALB) Fundamental Analysis & Valuation

NYSE:ALB • US0126531013

Current stock price

215.62 USD
+30.24 (+16.31%)
At close:
215.88 USD
+0.26 (+0.12%)
After Hours:

This ALB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALB Profitability Analysis

1.1 Basic Checks

  • In the past year ALB has reported negative net income.
  • ALB had a positive operating cash flow in the past year.
  • In multiple years ALB reported negative net income over the last 5 years.
  • ALB had a positive operating cash flow in each of the past 5 years.
ALB Yearly Net Income VS EBIT VS OCF VS FCFALB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

1.2 Ratios

  • ALB has a Return On Assets of -4.14%. This is in the lower half of the industry: ALB underperforms 67.07% of its industry peers.
  • With a Return On Equity value of -7.11%, ALB is not doing good in the industry: 62.20% of the companies in the same industry are doing better.
  • ALB has a worse Return On Invested Capital (0.37%) than 74.39% of its industry peers.
Industry RankSector Rank
ROA -4.14%
ROE -7.11%
ROIC 0.37%
ROA(3y)-1.15%
ROA(5y)3.02%
ROE(3y)-1.2%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
ALB Yearly ROA, ROE, ROICALB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • The Operating Margin of ALB (1.34%) is worse than 67.07% of its industry peers.
  • ALB's Operating Margin has declined in the last couple of years.
  • ALB has a Gross Margin of 13.00%. This is in the lower half of the industry: ALB underperforms 78.05% of its industry peers.
  • In the last couple of years the Gross Margin of ALB has declined.
Industry RankSector Rank
OM 1.34%
PM (TTM) N/A
GM 13%
OM growth 3Y-63.89%
OM growth 5Y-37.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-32.21%
GM growth 5Y-16.29%
ALB Yearly Profit, Operating, Gross MarginsALB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ALB Health Analysis

2.1 Basic Checks

  • ALB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ALB remains at a similar level compared to 1 year ago.
  • ALB has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALB has an improved debt to assets ratio.
ALB Yearly Shares OutstandingALB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ALB Yearly Total Debt VS Total AssetsALB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • ALB has an Altman-Z score of 2.80. This is not the best score and indicates that ALB is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.80, ALB is in the better half of the industry, outperforming 74.39% of the companies in the same industry.
  • ALB has a debt to FCF ratio of 4.61. This is a neutral value as ALB would need 4.61 years to pay back of all of its debts.
  • ALB's Debt to FCF ratio of 4.61 is fine compared to the rest of the industry. ALB outperforms 79.27% of its industry peers.
  • ALB has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
  • ALB has a Debt to Equity ratio of 0.33. This is in the better half of the industry: ALB outperforms 74.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 4.61
Altman-Z 2.8
ROIC/WACC0.03
WACC14.32%
ALB Yearly LT Debt VS Equity VS FCFALB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • ALB has a Current Ratio of 2.23. This indicates that ALB is financially healthy and has no problem in meeting its short term obligations.
  • ALB has a Current ratio (2.23) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.57 indicates that ALB should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.57, ALB is doing good in the industry, outperforming 65.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.57
ALB Yearly Current Assets VS Current LiabilitesALB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALB Growth Analysis

3.1 Past

  • ALB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.24%, which is quite impressive.
  • Looking at the last year, ALB shows a decrease in Revenue. The Revenue has decreased by -4.37% in the last year.
  • ALB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.45% yearly.
EPS 1Y (TTM)66.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.38%
Revenue 1Y (TTM)-4.37%
Revenue growth 3Y-11.1%
Revenue growth 5Y10.45%
Sales Q2Q%15.94%

3.2 Future

  • The Earnings Per Share is expected to grow by 94.11% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 11.41% on average over the next years. This is quite good.
EPS Next Y1065.95%
EPS Next 2Y264.36%
EPS Next 3Y149.67%
EPS Next 5Y94.11%
Revenue Next Year11.49%
Revenue Next 2Y8.65%
Revenue Next 3Y8.48%
Revenue Next 5Y11.41%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALB Yearly Revenue VS EstimatesALB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ALB Yearly EPS VS EstimatesALB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

3

4. ALB Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALB. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 28.26, ALB can be considered very expensive at the moment.
  • ALB's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 38.20. ALB is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 28.26
ALB Price Earnings VS Forward Price EarningsALB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALB indicates a slightly more expensive valuation: ALB is more expensive than 79.27% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALB is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 36.71
EV/EBITDA 32.21
ALB Per share dataALB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALB's earnings are expected to grow with 149.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y264.36%
EPS Next 3Y149.67%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ALB Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.94%, ALB is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.04, ALB has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, ALB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.94%

5.2 History

  • On average, the dividend of ALB grows each year by 14.86%, which is quite nice.
  • ALB has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ALB has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)14.86%
Div Incr Years31
Div Non Decr Years31
ALB Yearly Dividends per shareALB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • The earnings of ALB are negative and hence is the payout ratio. ALB will probably not be able to sustain this dividend level.
  • The dividend of ALB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-52.74%
EPS Next 2Y264.36%
EPS Next 3Y149.67%
ALB Yearly Income VS Free CF VS DividendALB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

More info and screens

Find the best dividend stocksShow peers with best dividend

ALB Fundamentals: All Metrics, Ratios and Statistics

ALBEMARLE CORP

NYSE:ALB (4/16/2026, 4:18:05 PM)

After market: 215.88 +0.26 (+0.12%)

215.62

+30.24 (+16.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-11
Earnings (Next)05-06
Inst Owners96.07%
Inst Owner Change0.03%
Ins Owners0.2%
Ins Owner Change-4.43%
Market Cap25.42B
Revenue(TTM)5.14B
Net Income(TTM)-677.38M
Analysts77.24
Price Target194.48 (-9.8%)
Short Float %8.5%
Short Ratio4.26
Dividend
Industry RankSector Rank
Dividend Yield 0.94%
Yearly Dividend3.04
Dividend Growth(5Y)14.86%
DP-52.74%
Div Incr Years31
Div Non Decr Years31
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)23.68%
Min EPS beat(2)-28.49%
Max EPS beat(2)75.86%
EPS beat(4)3
Avg EPS beat(4)57.57%
Min EPS beat(4)-28.49%
Max EPS beat(4)113.21%
EPS beat(8)3
Avg EPS beat(8)-20.89%
EPS beat(12)6
Avg EPS beat(12)-0.71%
EPS beat(16)10
Avg EPS beat(16)3.12%
Revenue beat(2)2
Avg Revenue beat(2)3.19%
Min Revenue beat(2)1.46%
Max Revenue beat(2)4.93%
Revenue beat(4)3
Avg Revenue beat(4)1.72%
Min Revenue beat(4)-7.88%
Max Revenue beat(4)8.39%
Revenue beat(8)5
Avg Revenue beat(8)0.57%
Revenue beat(12)6
Avg Revenue beat(12)-0.61%
Revenue beat(16)7
Avg Revenue beat(16)-0.65%
PT rev (1m)2.04%
PT rev (3m)56.88%
EPS NQ rev (1m)4.73%
EPS NQ rev (3m)456.92%
EPS NY rev (1m)1.51%
EPS NY rev (3m)519.78%
Revenue NQ rev (1m)0.38%
Revenue NQ rev (3m)12.52%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)7.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.26
P/S 4.94
P/FCF 36.71
P/OCF 19.82
P/B 2.67
P/tB 3.25
EV/EBITDA 32.21
EPS(TTM)-0.79
EYN/A
EPS(NY)7.63
Fwd EY3.54%
FCF(TTM)5.87
FCFY2.72%
OCF(TTM)10.88
OCFY5.04%
SpS43.62
BVpS80.87
TBVpS66.33
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -4.14%
ROE -7.11%
ROCE 0.47%
ROIC 0.37%
ROICexc 0.42%
ROICexgc 0.48%
OM 1.34%
PM (TTM) N/A
GM 13%
FCFM 13.46%
ROA(3y)-1.15%
ROA(5y)3.02%
ROE(3y)-1.2%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-69.86%
ROICexgc growth 5Y-39.71%
ROICexc growth 3Y-69.41%
ROICexc growth 5Y-37.84%
OM growth 3Y-63.89%
OM growth 5Y-37.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-32.21%
GM growth 5Y-16.29%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 4.61
Debt/EBITDA 4.29
Cap/Depr 89.54%
Cap/Sales 11.47%
Interest Coverage 0.38
Cash Conversion 176.29%
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 1.57
Altman-Z 2.8
F-Score5
WACC14.32%
ROIC/WACC0.03
Cap/Depr(3y)292.05%
Cap/Depr(5y)334.21%
Cap/Sales(3y)21.71%
Cap/Sales(5y)22.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.38%
EPS Next Y1065.95%
EPS Next 2Y264.36%
EPS Next 3Y149.67%
EPS Next 5Y94.11%
Revenue 1Y (TTM)-4.37%
Revenue growth 3Y-11.1%
Revenue growth 5Y10.45%
Sales Q2Q%15.94%
Revenue Next Year11.49%
Revenue Next 2Y8.65%
Revenue Next 3Y8.48%
Revenue Next 5Y11.41%
EBIT growth 1Y110.87%
EBIT growth 3Y-67.9%
EBIT growth 5Y-31.38%
EBIT Next Year2232.92%
EBIT Next 3Y201.65%
EBIT Next 5Y117.08%
FCF growth 1Y169.76%
FCF growth 3Y2.33%
FCF growth 5YN/A
OCF growth 1Y86.41%
OCF growth 3Y-12.4%
OCF growth 5Y9.93%

ALBEMARLE CORP / ALB Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ALBEMARLE CORP (ALB) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALB.


What is the valuation status of ALBEMARLE CORP (ALB) stock?

ChartMill assigns a valuation rating of 3 / 10 to ALBEMARLE CORP (ALB). This can be considered as Overvalued.


How profitable is ALBEMARLE CORP (ALB) stock?

ALBEMARLE CORP (ALB) has a profitability rating of 1 / 10.


What is the earnings growth outlook for ALBEMARLE CORP?

The Earnings per Share (EPS) of ALBEMARLE CORP (ALB) is expected to grow by 1065.95% in the next year.